https://efferon.com/ https://efferon.com/about/ https://efferon.com/tech/ https://efferon.com/indications/ https://efferon.com/news/ https://efferon.com/articles/ https://efferon.com/privacy-policy/ https://efferon.com/terms-of-use/ https://efferon.com/cookie-policy/ https://efferon.com/imprint/ https://efferon.com/distributors/ https://efferon.com/application/ https://efferon.com/de/ https://efferon.com/de/about/ https://efferon.com/de/tech/ https://efferon.com/de/indications/ https://efferon.com/de/news/ https://efferon.com/de/articles/ https://efferon.com/de/privacy-policy/ https://efferon.com/de/terms-of-use/ https://efferon.com/de/cookie-policy/ https://efferon.com/de/imprint/ https://efferon.com/de/distributors/ https://efferon.com/de/application/ https://efferon.com/products/efferon-lps/ https://efferon.com/products/efferon-neo/ https://efferon.com/de/products/efferon-lps/ https://efferon.com/de/products/efferon-neo/ https://efferon.com/news/efferon-on-espnic-2026/ https://efferon.com/news/efferonneo-receives-ce-mdr-mark/ https://efferon.com/news/efferon-at-isicem/ https://efferon.com/news/efferon-first-distributors-meeting/ https://efferon.com/news/efferon-is-now-available-in-poland/ https://efferon.com/news/efferonlps-is-available-in-costa-rica/ https://efferon.com/news/efferon-lps-is-now-approved-in-thailand/ https://efferon.com/news/efferon-lps-german-nephrology-guidelines-apheresis/ https://efferon.com/news/well-see-each-other-in-greece/ https://efferon.com/news/efferon-therapies-are-now-available-in-armenia/ https://efferon.com/news/clinical-data-confirmed-the-effectiveness-of-efferon-neo-in-children-with-sepsis/ https://efferon.com/news/efferon-lps-has-been-approved-in-the-kingdom-of-saudi-arabia/ https://efferon.com/news/antibiotic-removal-during-efferon-lps-hemoadsorption/ https://efferon.com/news/efferon-at-the-6th-asia-pacific-aki-crrt-congress-in-bangkok/ https://efferon.com/news/win-a-new-ipad-join-the-efferon-lps-photo-challenge-on-linkedin/ https://efferon.com/news/efferon-lps-device-approval-uk-croatia/ https://efferon.com/news/efferon-lps-now-available-in-italy/ https://efferon.com/news/applying-vicenzas-lessons/ https://efferon.com/news/efferon-expands-its-global-presence/ https://efferon.com/news/efferon-expands-to-new-markets-with-bertossi-partnership/ https://efferon.com/news/efferon-lps-becomes-available-in-romania/ https://efferon.com/news/distribution-agreements-in-european-countries/ https://efferon.com/news/efferon-lps-receives-ce-mark-under-eu-mdr/ https://efferon.com/news/results-of-lasso-mrct-published-in-shock/ https://efferon.com/news/efferon-at-lives-2022-in-paris/ https://efferon.com/news/efferon-participated-in-medica/ https://efferon.com/news/lasso-multicenter-randomized-trial-launched/ https://efferon.com/de/news/efferon-auf-espnic-2026/ https://efferon.com/de/news/efferon-neo-erhaelt-ce-mdr-kennzeichnung/ https://efferon.com/de/news/efferon-auf-dem-isicem/ https://efferon.com/de/news/efferons-erstes-distributoren-treffen/ https://efferon.com/de/news/efferon-jetzt-in-polen-verfuegbar/ https://efferon.com/de/news/efferon-lps-jetzt-in-costa-rica-verfuegbar/ https://efferon.com/de/news/efferon-lps-nun-in-thailand-zugelassen/ https://efferon.com/de/news/efferon-lps-leitlinien-deutsche-gesellschaft-nephrologie-apherese/ https://efferon.com/de/news/wir-sehen-uns-in-griechenland/ https://efferon.com/de/news/efferon-therapien-jetzt-in-armenien-verfuegbar/ https://efferon.com/de/news/klinische-daten-bestaetigen-wirksamkeit-efferon-neo-kinder-sepsis/ https://efferon.com/de/news/efferon-lps-zulassung-koenigreich-saudi-arabien/ https://efferon.com/de/news/extrakorporale-elimination-antibiotika-efferon-lps-haemoadsorption/ https://efferon.com/de/news/efferon-6th-asia-pacific-aki-crrt-congress-bangkok/ https://efferon.com/de/news/gewinnen-sie-ipad-efferon-lps-foto-challenge-linkedin/ https://efferon.com/de/news/efferon-lps-haemoadsorption-zulassung-vereinigtes-koenigreich-kroatien/ https://efferon.com/de/news/efferon-lps-jetzt-in-italien-verfuegbar/ https://efferon.com/de/news/learnings-aus-vicenza-in-der-praxis/ https://efferon.com/de/news/efferon-erweitert-globale-praesenz/ https://efferon.com/de/news/efferon-erschliesst-neue-maerkte-partnerschaft-bertossi/ https://efferon.com/de/news/efferon-lps-jetzt-auch-in-rumaenien-verfuegbar/ https://efferon.com/de/news/neue-vertriebsvereinbarungen-in-europaeischen-laendern/ https://efferon.com/de/news/efferon-lps-erhaelt-ce-kennzeichnung-eu-mdr/ https://efferon.com/de/news/ergebnisse-lasso-mrct-studie-in-shock-veroeffentlicht/ https://efferon.com/de/news/efferon-auf-lives-kongress-2022-in-paris/ https://efferon.com/de/news/efferon-teilnahme-medica/ https://efferon.com/de/news/lasso-multizentrische-randomisierte-studie-gestartet/ https://efferon.com/articles/eferon-lps-neo-pediatric-sepsis-multicenter-study/ https://efferon.com/articles/lps-hemoadsorption-hemodiafiltration-gram-negative-sepsis-study/ https://efferon.com/articles/efferon-lps-neo-hemoperfusion-pediatric-sepsis-reverts-multiple-organ-failure/ https://efferon.com/articles/hemoperfusion-lps-mesoporous-polymeric-adsorbent-septic-shock-multicenter-rct/ https://efferon.com/articles/efferon-lps-hemoperfusion-intra-abdominal-sepsis-biomarkers/ https://efferon.com/articles/extracorporeal-cytokine-adsorption-crs-leukemia-car-t-case-clinical-observation/ https://efferon.com/articles/efferon-lps-hemoperfusion-simultaneous-endotoxin-cytokine-removal-septic-shock/ https://efferon.com/articles/hemosorption-styrene-divinylbenzene-copolymer-lps-ligand-acute-lung-injury-case/ https://efferon.com/articles/adsorbent-styrene-divinylbenzene-copolymer-lps-ligand-hemoperfusion-sepsis/ https://efferon.com/articles/efficiency-safety-new-lps-selective-hemosorption-product-experimental-study/ https://efferon.com/articles/polymeric-sorbent-method-for-production-and-use/ https://efferon.com/articles/method-for-determination-of-bacterial-endotoxin-in-fluids/ https://efferon.com/articles/methods-for-determination-of-bacterial-endotoxin-critical-care-review/ https://efferon.com/articles/sorbents-for-extracorporeal-removal-of-toxic-substances-and-molecules-review/ https://efferon.com/de/articles/multimodale-lps-haemoadsorption-haemodiafiltration-gramnegative-sepsis-studie/ https://efferon.com/de/articles/eferon-lps-neo-haemoadsorption-paediatrische-sepsis-multizentrische-studie/ https://efferon.com/de/articles/efferon-lps-neo-haemoperfusion-paediatrie-rueckbildung-multiorganversagen/ https://efferon.com/de/articles/haemoperfusion-lps-mesoporoeses-polymer-adsorbens-septischer-schock-rct/ https://efferon.com/de/articles/efferon-lps-haemoperfusion-intraabdominale-sepsis-vitalparameter-biomarker/ https://efferon.com/de/articles/extrakorporale-zytokinadsorption-crs-leukaemie-car-t-klinische-beobachtung/ https://efferon.com/de/articles/efferon-lps-haemoperfusion-entfernung-endotoxin-zytokine-septischer-schock/ https://efferon.com/de/articles/haemosorption-styrol-divinylbenzol-copolymer-lps-ligand-lungenversagen-fall/ https://efferon.com/de/articles/adsorbens-styrol-divinylbenzol-copolymer-lps-ligand-haemoperfusion-sepsis/ https://efferon.com/de/articles/wirksamkeit-sicherheit-neues-lps-selektives-haemosorption-produkt-studie/ https://efferon.com/de/articles/polymeres-adsorbens-verfahren-herstellung-verwendung/ https://efferon.com/de/articles/methode-bestimmung-bakterieller-endotoxine-biologische-fluessigkeiten/ https://efferon.com/de/articles/methoden-bestimmung-bakterieller-endotoxine-intensivmedizin-uebersichtsarbeit/ https://efferon.com/de/articles/entfernung-toxischer-substanzen-unerwuenschte-molekuele-uebersichtsarbeit/ https://efferon.com/application/cpb/ https://efferon.com/application/rrt-postfilter/ https://efferon.com/application/rrt-prefilter/ https://efferon.com/application/rrt-hemoperfusion/ https://efferon.com/de/application/cpb/ https://efferon.com/de/application/rrt-postfilter/ https://efferon.com/de/application/rrt-prefilter/ https://efferon.com/de/application/rrt-hemoperfusion/